SCHEMBL5605671

SCHEMBL5605671

[CH]=Nc1ccc(OCc2cccc(COc3ccc(C(C)(C)c4ccc(O)cc4)cc3)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.45
ESR2 Q92731 3/20 0.45
SLC6A2 P23975 2/20 0.45
SLC6A3 Q01959 2/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
PTGS1 P23219 1/20 0.45
CYP2C19 P33261 1/20 0.45
PTGS2 P35354 1/20 0.45
HIF1A Q16665 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
PKM P14618 2/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
THRB P10828 1/20 0.43
CASP3 P42574 1/20 0.43
RECQL P46063 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5972792 0.83 PKM (0.48) ESR1ESR2SLC6A2SLC6A3LMNA
SCHEMBL5972797 0.82 PKM (0.47) ESR1ESR2SLC6A2SLC6A3LMNA
Hydrochloric Acid SCHEMBL8000443 0.82 MAOB (0.59) ESR1ESR2SLC6A2SLC6A3LMNA
SCHEMBL6553509 0.81 MAOB (0.54) ESR1ESR2SLC6A2SLC6A3LMNA
SCHEMBL6059951 0.79 SLC6A2 (0.73) ESR1ESR2SLC6A2SLC6A3LMNA
SCHEMBL5605698 0.79 PKM (0.44) PKMALDH1A1KDM4EMEN1GAA
SCHEMBL4993768 0.79 PKM (0.46) PKMALDH1A1KDM4EMEN1GAA
SCHEMBL4999957 0.79 F2 (0.72) F2
SCHEMBL31506335 0.79 F2 (0.72) F2
SCHEMBL13140115 0.79 F2 (0.53) ESR1ESR2SLC6A2SLC6A3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1572179-B1 PHARMACEUTICAL COMPOSITION COMPRISING A LTB4 ANTAGONIST AND A COX-2 INHIBITOR OR A COMBINED COX1/2 INHIBITOR BOEHRINGER INGELHEIM PHARMA (DE) 2007-02-28 EP disclosed
EP-1572179-A1 PHARMACEUTICAL COMPOSITION COMPRISING A LTB4 ANTAGONIST AND A COX-2 INHIBITOR OR A COMBINED COX1/2 INHIBITOR Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2005-09-14 EP disclosed
US-20040116516-A1 Pharmaceutical composition BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-06-17 US disclosed
WO-2004047824-A1 PHARMACEUTICAL COMPOSITION COMPRISING A LTB4 ANTAGONIST AND A COX-2 INHIBITOR OR A COMBINED COX1/2 INHIBITOR BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-06-10 WO disclosed